| NCT ID | NCT06082661 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2022-06-23 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2022-06-23 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this biospecimen collection protocol is the acquisition of blood from adult volunteers. These biospecimens will be transferred to the College of Medicine (COM)/Burnett School of Biomedical Sciences (BSBS) research scientists and their research teams for testing according to their separate IRB-approved/exempted protocols. These separate IRBapproved protocols cannot be for genetic testing.
Eligibility Criteria
Inclusion Criteria: * Male or female adults * 18 years old or older * weigh over 110 pounds * able to provide informed consent Exclusion Criteria: * pregnant/suspect to be pregnant * prisoners * have donated blood anywhere in the preceding 16 weeks
Frequently Asked Questions
Who can join the NCT06082661 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06082661 currently recruiting?
Yes, NCT06082661 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Central Florida to inquire about joining.
Where is the NCT06082661 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06082661 clinical trial?
NCT06082661 is sponsored by University of Central Florida. The trial plans to enroll 5,000 participants.